Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Dassault Systèmes and Accelrys to Join Forces

Published: Friday, January 31, 2014
Last Updated: Friday, January 31, 2014
Bookmark and Share
Delivering Scientific Innovation in the Age of Experience

Dassault Systèmes, the world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions and Accelrys, Inc., a leading provider of scientific innovation lifecycle management software for chemistry, biology and materials, have announced the signing of a definitive merger agreement for Dassault Systèmes to acquire San Diego-based Accelrys, Inc.  Under the terms and conditions of the merger agreement, Dassault Systèmes will make an all cash tender offer for all of the outstanding shares of Accelrys common stock at a price of $12.50 per share, without interest, representing a fully diluted equity value for Accelrys of approximately $750 million. Dassault Systèmes intends to acquire any shares of Accelrys not tendered into the tender offer, via a merger that will be effected as soon as possible after the closing of the tender offer.

Combining with Accelrys will enrich the molecular chemistry capabilities from discovery to manufacturing and regulatory requirements of Dassault Systèmes’ formulation-based industry offerings such as life sciences, consumer packaged goods, high tech and energy, as well as advanced manufacturing industries.

“With Max Carnecchia and his teams, we share the same passion for enabling scientific innovation and are confident that together, leveraging the great Accelrys assets, we will deliver a unique and unmatched scientific PLM solution.” said Bernard Charlès, President and CEO, Dassault Systèmes. “The World demands a new paradigm for sustainability where chemistry, materials and biology meet. This is what the virtual universes enabled by Dassault Systèmes are delivering, capable of harmonizing products, nature and life, from imagination to industry solution experience.”

“This merger represents a unique opportunity to accelerate Accelrys’ journey by leveraging Dassault Systèmes’ PLM environment and 30 years of unmatched discipline in executing for improved industrial performance.” said Max Carnecchia, President and CEO of Accelrys. “With our passionate and talented teams, Accelrys is convinced that joining Dassault Systèmes will deliver transformational value to our customers by combining science-based innovation with product lifecycle management.”

Accelrys’ list of 2,000 customers includes many of the Fortune 500 companies, with major industry players in pharma/biotech, consumer packaged goods and chemical including Sanofi, Pfizer, GSK, AstraZeneca, Du Pont, Shell, BASF, P&G, Unilever and L’Oréal.

The Board of Directors of Accelrys has unanimously approved the transaction. The transaction is expected to be completed during the second quarter of 2014, subject to Accelrys shareholders tendering a majority of Accelrys’ outstanding shares in the tender offer to be launched in the coming days, receipt of certain regulatory approvals and other customary closing conditions.

Foros acted as financial advisor and Cravath, Swaine & Moore LLP provided legal advice to Dassault Systèmes. Accelrys was advised by Morgan Stanley & Co. LLC, and by Paul Hastings LLP for legal advice.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ALMA Welcomes Accelrys as a Premium Sponsor
Association of Lab Managers (ALMA) now supported by leading lab software provider Accelrys
Friday, April 04, 2014
Accelrys Acquires QUMAS
The acquisition extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions.
Tuesday, December 10, 2013
Accelrys Receives Highest Rating in Gartner's Latest Laboratory Informatics System Report
Accelrys was the only vendor to achieve the highest possible rating in all five categories of new product development (NPD)
Friday, October 11, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Cambridge Isotope Laboratories, Inc. is deploying the Accelrys Laboratory Execution System (LES) and three applications within the Accelrys Laboratory Information Management System.
Tuesday, September 10, 2013
Accelrys Acquires Environmental Health and Safety Leader ChemSW
Chemical inventory management solutions improve compliance and sustainability impact of Accelrys’ Scientific Innovation Lifecycle Management portfolio
Wednesday, September 04, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Enterprise implementation follows successful pilot that achieved a 78 percent reduction in data review times and a 40 percent overall improvement in lab processing time
Sunday, September 01, 2013
The Evolution of the Integrated Platform: Accelrys' One-Two Punch
A look at how Accelrys is delivering an integrated platform of enterprise laboratory solutions.
Sunday, June 02, 2013
Accelrys and eMolecules Collaborate to Enhance Accelrys Available Chemicals Directory
Validated and curated in-stock compounds from eMolecules now accessible through Accelrys ACD
Saturday, April 06, 2013
Accelrys' Electronic Laboratory Notebooks Recognized in Gartner's Enterprise Category
Accelrys' electronic laboratory notebooks (ELN) as "very high" or "high" in each scientific and functional domain in a recent report by Gartner, Inc.
Sunday, March 03, 2013
Accelrys® ELN Delivers Seamless Integration with the Reaxys® Workflow Solution
New chemistry information management possibilities for research scientists arising from Accelrys' cooperation with Elsevier.
Sunday, March 03, 2013
Accelrys, Inc. Acquires Vialis AG
Accelrys Strengthens Leadership Position in Laboratory Informatics Market
Sunday, February 10, 2013
Accelrys Acquires Systems Integrator Vialis
Accelrys has acquired Vialis AG to solidify its market leadership in the laboratory informatics space
Sunday, January 20, 2013
German Cancer Research Center Selects Contur ELN from Accelrys
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has licensed the server-based, on-premises version of Accelrys' Contur Electronic Lab Notebook (ELN).
Friday, December 28, 2012
Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
Aquavit to utilize Accelrys Enterprise Platform to develop advanced medical software
Sunday, November 11, 2012
Accelrys Acquires Aegis Analytical Corp. for $30 million in cash
New enterprise manufacturing process intelligence software capabilities expand Accelrys' footprint in downstream product development and commercialization operations
Sunday, November 11, 2012
Scientific News
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
New Autism Genes Are Revealed in Largest-Ever Study
Work draws more detailed picture of genetic risk, sheds light on sex differences in diagnosis.
Influenza A Viruses More Likely To Emerge In East Asia Than North America
Novel strains of influenza A are more likely to emerge in East Asia than in North America, according to a global analysis by the One Health Institute at the UC Davis School of Veterinary Medicine and EcoHealth Alliance.
Bone Risks Linked to Genetic Variants
A large-scale genomic study uncovered novel genetic variants and led researchers to an unexpected gene that affects bone density and fracture risk.
The Final Word on STAP
Researchers fail to replicate STAP study; computational analysis reveals genomic inconsistency.
Study Adds to Evidence That Viruses Are Alive
A new analysis supports the hypothesis that viruses are living entities that share a long evolutionary history with cells, researchers report.
CSI -- On The Metabolite's Trail
Bioinformaticians at the University of Jena make the most efficient search engine for molecular structures available online.
Potential Ovarian Cancer Biomarker Isolated
Researchers from North Carolina State University utilized a highly sensitive mass spectrometry analysis to identify and measure difficult-to-detect N-glycan biomarkers associated with ovarian cancers in stages I – IV.
Smartphone App to Monitor Serious Blood Disorder
A researcher from Florida Atlantic University has come up with a unique way to monitor sickle cell disease -- a serious blood disorder -- using a smart phone.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos